Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (207)	6/1/2003 1:58:14 AM
From: Madharry	Read Replies (1) of 590

Is it possible that they believe the sample patient population that they have might somehow be skewed and there fore they want to expand it by 50 to see if they end up with the same percentages? They seem to think there is a strong correlation between success and patients getting a skin rash. anyone buy into that? What is the downside here if this drug does not get approved? From what i can understand with my limited knowledge and intelligence- it sounds like what they have merits going forward but not full tilt. It seems to me like they want to convince both the FDA and themselves that the drug will be powerful enough to merit production and marketing, and no one is convinced of that yet.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next